Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
August 4th, 2022
The combination of laser capture microdissection and microfluidic RT-qPCR provides anatomic and biotechnical specificity in measuring the transcriptome in single neurons and glia. Applying creative methods with a system's biology approach to psychiatric disease may lead to breakthroughs in understanding and treatment such as the neuroinflammation antireward hypothesis in addiction.
The protocol is highly sensitive and allows high throughput capture of gene expression profile at single cell resolution. The technique provides both anatomical spatial and molecular specificity at single cell resolution. After harvesting the brain, selecting the single cells, and preparing the mRNA, inject control line fluid into the qPCR chip for priming.
Insert the qPCR chip into the microfluidic mixing device. Select the Prime script and run the program. After the completion of the program, remove the primed qPCR chip and pipette six microliters of the reaction from the PCR sample plate into the corresponding sample well in the primed qPCR chip.
Now, pipette six microliters of the reaction from the PCR assay plate into the corresponding assay well in the primed qPCR chip. Then insert the chip into the microfluidic mixing device. Select the Load Mix script and run the program.
Turn on the microfluidic RT-qPCR platform and warm up the bulb. Remove the qPCR chip from the microfluidic mixing device and peel the protective sticker from the bottom of the chip. Open the microfluidic RT-qPCR platform and load the qPCR chip into the platform.
Launch the data collection software by clicking on Start a New Run. Verify the chip barcode and chip type. Then click on next.
Select the chip run file and browse the file location for the data collection storage. Then click on Application Type and select Gene Expression. Select ROX for a passive reference, single probe, and EVAGreen for probe type.
Click to select the thermal cycling program and select Biomark HD GE:Fast 96x96 PCR+Melt v2. pcl file. Download the data analysis software.
Launch the software to analyze the microfluidic RT-qPCR experiment. Click Chip Run and open the ChipRun. bml file that was created by the experimenter.
A window displaying the experimental details including the passive reference, probe, and PCR thermal program will pop up. Under the Chip Explorer tab, click Sample Plate Setup and create a new sample plate template. Copy and paste the sample labels into the software spreadsheet as per the experimental design.
Enter the sample name and the RNA concentration used for the standard samples. Now, map the sample set up by clicking map from the task menu and selecting SBS96-Left.dsp. Next, select Detail Views to update these changes in the file and click Analyze.
Select Detector Plate Setup and create a new assay plate. Select the appropriate container type and format. Paste the assay names as per the experimental design and click on Analyze.
In the analysis settings pane, click the User and set the fit to auto. Now, manually review each reaction in the 96x96 chip. Visualize the amplification and melt curves to determine if each reaction followed the expected qPCR pattern.
If the amplification or melt curve does not match with what is expected, fail that reaction. Following QC, export the data by selecting file, clicking export, and saving the dataset as a csv file. As the exported csv file has both a pass fail matrix and a matrix with raw CT values, use the pass fail matrix to replace any failed cells in the dataset with NA.Download the recent version of open Source R software and then download the R Studio application.
For median centering, use the R software to calculate the median CT value calculated from all the CT values for an individual sample and then subtract all individual CT values from this median value to get a minus delta CT value. For housekeeping gene normalization, calculate the average expression of the housekeeping genes for each sample and use this value to subtract the individual CT values. To generate a minus delta delta CT value, run the code in the R software.
Upload the normalized dataset into R and analyze the data using the scale function, generate the scaled data, and then use the R heat map function or separate software to generate a heat map. To organize the data set for other functionality, calculate the Pearson correlations between each gene followed by the melt function. Export and upload this data into a gene correlation network software.
Neurons showed elevated expression of NeuN and microglial samples showed significant expression of the microglial markers Cd34 and Cx3xr1. The Th+neuronal samples demonstrated significantly elevated expression of Th compared to Th-neuronal and microglia samples. The Th-neurons displayed significant expression of Gcg, suggesting that Th-neuronal samples are enriched with neurons that use Glp1 as a neurotransmitter.
Linear discriminate analysis showed that these three cell types had differing gene expression profiles across all 65 genes. Cellular sub phenotypes of Glp1 enriched neuron samples through an alcohol withdrawal time series were represented using heat maps. The sub phenotype A, which highly expresses the inflammatory gene cluster one increases in ratio at the eight hour withdrawal time point and reaches a maximum at 32 hour withdrawal.
The inflammatory sub phenotype is normalized to control by 176 hour withdrawal. Sub phenotype B, which highly expresses GABA receptor gene cluster two demonstrates an overall suppression in the expression of this gene cluster by the 176 hour withdrawal condition. The gene expression of individual samples was combined into averages so that the expression of gene clusters and the protein location of that gene transcript could be visualized throughout the time series.
This technique can be applied to any biological system or tissue to understand the cellular response to a disease or a perturbation. That is to decipher the molecular response at single cell resolution relating to the spatial and the anatomical architecture of the tissue.
View the full transcript and gain access to thousands of scientific videos
Overview
This study leverages laser capture microdissection and microfluidic RT-qPCR to analyze transcriptomes in individual neurons and glia. It emphasizes the method's high sensitivity and specificity, which can advance our understanding of psychiatric diseases associated with neuroinflammation, particularly in the context of addiction.
Key Study Components
Area of Science
- Neuroscience
- Transcriptional Analysis
- Psychiatric Disorders
Background
- Understanding RNA expression patterns in neurons and glial cells is crucial for elucidating psychiatric diseases.
- Previous methods lacked both anatomical spatial and molecular specificity.
- Neuroinflammation has been implicated in the antireward hypothesis of addiction.
Purpose of Study
- To develop a sensitive method for capturing gene expression profiles at single-cell resolution.
- To analyze how these molecular changes relate to behavioral responses in psychiatric conditions.
- To assess neuroinflammation's role in addiction-related mechanisms.
Methods Used
- Microfluidic RT-qPCR was employed, enabling high-throughput data collection from single cells.
- Single cells were isolated from brain tissue post-harvesting for mRNA preparation and analysis.
- Detailed protocols for chip priming, data collection, and analysis were implemented.
- Gene expression data were validated and analyzed using statistical software.
Main Results
- Neurons exhibited elevated expression of NeuN, while microglia showed significant expression of Cd34 and Cx3xr1.
- Different subtypes were identified based on gene expression profiles, notably in response to withdrawal and neuroinflammation.
- Key conclusions regarding gene clusters and their regulation during withdrawal stress were drawn from heat map analyses.
Conclusions
- The study demonstrates that combining these methodologies allows for an enriched understanding of cell-type-specific responses to neuroinflammation.
- Insights gained could aid in developing targeted therapeutic approaches for psychiatric disorders involving addiction.
Frequently Asked Questions
Executive Industry Relevance
Single-cell gene expression profiling with anatomical specificity enables mechanistic de-risking in neuropsychiatric target discovery, particularly for addiction and antireward pathways. This approach provides high-resolution insight into neuroinflammatory drivers, supporting predictive confidence at the intersection of molecular pathology and behavioral phenotypes. Integrating these methods into early discovery pipelines enhances portfolio triage and translational continuity for CNS drug development.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neuroinflammatory and antireward hypotheses at single-cell resolution.
- Supports functional target validation by linking gene expression to anatomical and phenotypic specificity.
- Facilitates mechanistic de-risking for CNS targets implicated in addiction and withdrawal.
- Improves predictive confidence for advancing neuropsychiatric targets.
Screening & Assay Development
- Prepares validated cellular systems for downstream transcriptomic and phenotypic screening.
- Delivers quantitative, reproducible gene expression outputs for assay standardization.
- Enables high-throughput analysis of gene networks across defined cell types.
- Supports reliable evaluation of compound effects on neuroinflammatory pathways.
Translational & Preclinical Research
- Aligns molecular findings with disease-relevant neuroanatomical systems in addiction models.
- Provides continuity from discovery through preclinical validation of neuroinflammatory biomarkers.
- Informs risk-adjusted advancement decisions for CNS therapeutic programs.
- Enhances translational biomarker development by mapping gene expression to withdrawal phenotypes.
Pipeline & Workflow Integration
This method bridges early discovery and preclinical research by enabling high-throughput, anatomically precise gene expression analysis in CNS tissues.
- Discovery Biology: Supports hypothesis testing and pathway clarification for neuroinflammation and antireward mechanisms.
- Screening: Provides reproducible, quantitative gene expression data for assay development and compound screening.
- Analytics: Generates scalable datasets for network analysis, heat mapping, and statistical comparison of cellular phenotypes.
- Translational Research: Connects molecular signatures to disease-relevant withdrawal states and biomarker alignment.
- Enterprise Reuse: Offers a reusable platform for single-cell transcriptomics across diverse CNS and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in CNS target validation.
- Operational Value: Delivers standardized, scalable, and reproducible single-cell gene expression workflows.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio management in neuropsychiatric R&D.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of CNS therapeutic candidates.
Implementation Considerations
- Requires expertise in laser capture microdissection and microfluidic RT-qPCR platforms.
- Demands robust analytical infrastructure for high-throughput data processing and network analysis.
- Necessitates cross-team standardization of sample preparation and data normalization protocols.
- Adaptable to various CNS tissues and disease models with appropriate optimization.
- Dependent on access to specialized instrumentation and bioinformatics support.
